Loading people...
Estelle Botbol is a Europe-based Principal on the Health and TechBio team at SpeedInvest, where she sources early-stage digital health and biotechnology startups across the region. Prior to her current role, she served as an Associate at Amsterdam-based Inkef Capital, focusing on life sciences, therapeutics, and medical technology investments. During her tenure, she held board observer positions at several portfolio companies, including TargED Biopharmaceuticals, VarmX, NMD Pharma, and Onward Medical, which successfully completed an initial public offering. Before entering venture capital, she co-founded Nanoshield, a startup dedicated to developing antimicrobial nanomaterials for medical devices. She holds a Master's degree in Applied Biosciences and Biotechnology from Imperial College London and a Bachelor's degree in Microbiology and Immunology from McGill University. Her career combines foundational scientific expertise with institutional investment experience to support emerging therapeutic and medical technology ventures.
Estelle Botbol is a key member of the investment team at INKEF Capital, where she holds the position of Associate. INKEF Capital is a leading European venture capital firm known for its strategic investments in groundbreaking healthcare and technology companies. As an Associate, Estelle plays a crucial role in the firm's investment process, from initial market research and deal sourcing to comprehensive due diligence and portfolio support.
Her responsibilities at INKEF Capital involve identifying nascent trends and disruptive technologies across various markets. She actively seeks out promising startups and innovative companies that align with INKEF's investment thesis, particularly those poised to make a significant impact in their respective fields. Estelle's analytical skills are vital in evaluating potential investments, assessing business models, market potential, and management teams to ensure alignment with INKEF's rigorous investment criteria.
Estelle's career background likely reflects a strong foundation in finance, entrepreneurship, or relevant industry sectors, equipping her with the expertise to navigate the complexities of venture capital. Professionals in her role often bring experience in investment banking, consulting, or operational roles within high-growth companies, providing a multifaceted perspective on business development and strategic growth. This diverse background enables her to effectively engage with founders and entrepreneurs, understanding their challenges and opportunities.
While specific notable investments directly led by Estelle Botbol are typically part of the broader INKEF Capital portfolio, her contributions are integral to the firm's success in identifying and nurturing future industry leaders. She works closely with senior partners and the wider investment team to support portfolio companies, helping them scale and achieve their strategic objectives. Her involvement ensures that INKEF Capital continues to build a robust portfolio of innovative enterprises that are shaping the future of healthcare and technology.
Estelle Botbol's dedication to discovering and supporting transformative companies underscores her commitment to the venture capital ecosystem. Her work at INKEF Capital reinforces the firm's reputation as a discerning investor, committed to fostering innovation and driving value creation across its diverse portfolio.
Estelle Botbol is an Associate at INKEF Capital, a European venture capital firm. She is involved in identifying, evaluating, and executing investment opportunities, primarily in the healthcare and technology sectors.
As an Associate at INKEF Capital, Estelle Botbol focuses on investments in innovative companies within the healthcare and technology sectors. She helps identify startups with high growth potential that align with INKEF's strategic investment thesis.
Estelle Botbol works at INKEF Capital, a prominent European venture capital firm. INKEF Capital is known for its investments in groundbreaking healthcare and technology companies.
